ARK Investment Management - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q4 2021$107,164,000
-51.5%
7,862,379
-41.8%
0.32%
-39.0%
Q3 2021$221,157,000
-15.2%
13,501,650
-12.9%
0.53%
+9.5%
Q2 2021$260,747,000
-23.7%
15,492,997
-17.2%
0.48%
-28.6%
Q1 2021$341,775,000
+117.9%
18,717,144
+117.2%
0.68%
+62.8%
Q4 2020$156,851,000
+660.4%
8,618,165
+645.3%
0.42%
+241.8%
Q3 2020$20,628,0001,156,2970.12%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2021
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders